Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Replication-induced DNA secondary structures drive fork uncoupling and breakage. | EMBO J | 2023 | 37781931 | PubTator, text mining | PubMed |
| The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers. | Asian Pac J Cancer Prev | 2023 | 37774066 | PubTator, text mining | PubMed |
| Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer. | Int J Mol Sci | 2023 | 37762691 | PubTator, text mining | PubMed |
| Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors. | Genes (Basel) | 2023 | 37761922 | PubTator, text mining | PubMed |
| Genomic Instability of G-Quadruplex Sequences in Escherichia coli: Roles of DinG, RecG, and RecQ Helicases. | Genes (Basel) | 2023 | 37761860 | PubTator, text mining | PubMed |
| The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking. | Diagnostics (Basel) | 2023 | 37761329 | PubTator, text mining | PubMed |
| Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations. | Biomedicines | 2023 | 37761010 | PubTator, text mining | PubMed |
| Investigation of (Epi)genetic causes in syndromic short children born small for gestational age. | Eur J Med Genet | 2023 | 37758162 | PubTator, text mining | PubMed |
| Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. | Clin Cancer Res | 2023 | 37756555 | PubTator, text mining | PubMed |
| A Narrative Review of Breastfeeding and Its Correlation With Breast Cancer: Current Understanding and Outcomes. | Cureus | 2023 | 37750138 | PubTator, text mining | PubMed |
| Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges. | Front Oncol | 2023 | 37746296 | PubTator, text mining | PubMed |
| Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies. | Br J Cancer | 2023 | 37740039 | PubTator, text mining | PubMed |
| Ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis. | Pathology | 2023 | 37739924 | PubTator, text mining | PubMed |
| High-grade serous ovarian carcinoma, the "Achiles' hill" for clinicians and molecular biologists: a molecular insight. | Mol Biol Rep | 2023 | 37737967 | PubTator, text mining | PubMed |
| Long non-coding RNA AC099850.4 correlates with advanced disease state and predicts worse prognosis in triple-negative breast cancer. | Front Med (Lausanne) | 2023 | 37727755 | PubTator, text mining | PubMed |
| Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue. | Breast Cancer Res Treat | 2023 | 37725154 | PubTator, text mining | PubMed |
| Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer. | JAMA Netw Open | 2023 | 37721753 | PubTator, text mining | PubMed |
| BRCA1 frameshift variants leading to extended incorrect protein C termini. | HGG Adv | 2023 | 37718511 | PubTator, text mining | PubMed |
| The molecular details of a novel phosphorylation-dependent interaction between MRN and the SOSS complex. | Protein Sci | 2023 | 37705456 | PubTator, text mining | PubMed |
| Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC). | Curr Probl Cancer | 2023 | 37704491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=20